뉴로핏 (Neurophet)

[#Neurophet_Conference] Meet Neurophet at JSNM (Japanese Society of Nuclear Medicine)!    JSNM was established in 1964 and it has constantly grown with the mission to develop appropriate applications of radioactive substances and stable nuclides in medicine.      Neurophet will showcase AI-powered brain imaging analysis solutions, including brain PET image analysis software "Neurophet SCALE PET".    Optimizing treatments through accurate diagnosis is crucial for many diseases and nuclear medicine plays a key role in both diagnosis and therapy.    Neurophet SCALE PET provides quantitative regional amyloid beta deposition, known as the causative agent of Alzheimer's disease, using PET images. Especially, it has been officially recognized for enhanced reimbursement under Japan's health insurance scheme.    Visit our booth and discover how Neurophet transforms clinical workflow with AI technology!    📅 November 7-9, 2024   📍 Pacifico Yokohama Conference Center, Japan   ⭐ Booth #11     #Neurophet #JSNM #Japan #Nuclear_medicine #Alzheimers_disease #brain_image_analysis #Neurophet_SCALE_PET 

[#Neurophet_Issue]    Neurophet signs exclusive sales agreement with Beijing LADO Technology. Through this partnership, Neurophet has secured a pathway into the Chinese market. The agreement covers the distribution of brain PET image analysis (PET tracer deposition) software 'Neurophet SCALE PET' and includes the establishment of a joint venture in China.     Read more👉 https://bit.ly/48vGJyb    #Neurophet #Beijing_LADO_Technology #China #sales_agreement #partnership #Neurophet_SCALE_PET #Alzheimers_disease #brain_image_analysis  

[#Neurophet_Conference] Neurophet will be exhibiting at CTAD, and we can't wait to welcome you! Join us at the 17th annual CTAD conference for a meeting focused on Alzheimer’s disease therapeutic trials with key leaders in Alzheimer’s disease research from industry and academia.  Our CBO YoungJoon Moon, and medical director Jessica H.W. Kim, MD, MSc will be there to have insightful discussions and to form partnerships for the development of effective treatments to overcome the disease. 📅 October 29 – November 1, 2024   📍Madrid Marriott Auditorium Hotel & Conference Center, Spain Looking forward to seeing you there! #Neurophet #Alzheimers_disease #clinical_trials #Alzheimers_disease_treatment #lecanemab #donanemab #brain_image_analysis #neurology

It has been a true honor to have had the privilege of moderating Neurophet's panel discussion with esteemed Alzheimer’s experts: Professors Stephen Salloway, Won-Jin Moon, M.D., Kee Hyung Park, and Hyun Kook Lim. Professor Salloway has joined Neurophet as our Scientific Advisor. I am thrilled to collaborate with him to drive advancements that will benefit patients suffering by Alzheimer’s as the Medical Director of Neurodegenerative Disorders. We've had so many important discussions throughout this week, especially focusing on how our AI technologies could have and will help Alzheimer’s patients in the real-world scenarios. Our commitment to advancing the field of Alzheimer’s will continuously expand, in partnership with our esteemed global advisors. #Neurophet #Alzheimers #CTAD2024

[#Neurophet_Issue]    Last week, Neurophet hosted symposium and we were excited to receive significant interest from many medical professionals. Our scientific advisor, Professor Stephen Salloway captivated the audience with his presentation on “Safe Use of Amyloid-Lowering Antibodies in Clinical Practice.”   Additionally, Won-Jin Moon, professor of Radiology at Konkuk University Medical Center delivered a session titled “Imaging recommendations and practice for ARIA monitoring.” A heartfelt thank you to everyone who attended our symposium and expressed interest in our products.❤️👋   Read more👉 https://bit.ly/4dOnTn6     #Neurophet #symposium #Professor_Stephen_Salloway #Alzheimers_disease #Alzheimers_disease_treatment #brain_image_analysis #neurology #psychiatry

[#Neurophet_Issue]     📸Snap shots from the internal event with Professor Stephen Salloway!    Professor Stephen Salloway came all the way from the U.S. for Neurophet symposium, and he also visited Neurophet to encourage Neuropeans working and developing brain image analysis technology for safe use of Alzheimer's disease treatment.    A heartfelt thank you to Neuropeans for celebrating and Professor Stephen Salloway for friendly chat with us!❤️   #Neurophet #symposium #Professor_Stephen_Salloway #Alzheimers_disease #Alzheimers_disease_treatment #ARIA #brain_image_analysis #neurology #psychiatry 

[#Neurophet_Issue]    What an incredible time with Professor Stephen Salloway at Neurophet Symposium!✨   Neurophet recently appointed Professor Stephen Salloway as scientific advisor. He is a professor of Neurology and Psychiatry at the Warren Alpert Medical School of Brown University, and he also serves as the Founding Director of Memory and Aging Program at Butler Hospital in the U.S.    The highlight was Professor Stephen Salloway’s presentation on “Safe Use of Amyloid-Lowering Antibodies in Clinical Practice.”    The objective of this symposium was to provide an understanding of the safe use of Alzheimer's disease treatment and ARIA monitoring.🧠   In addition to presentations, medical professionals who participated in the symposium shared insightful discussions on Alzheimer's disease treatment.    A huge thank you to everyone who participated in Neurophet Symposium and especially to Professor Stephen Salloway.  Your support and engagement made it a fantastic event!🎉   #Neurophet #symposium #Professor_Stephen_Salloway #Alzheimers_disease #Alzheimers_disease_treatment #ARIA #brain_image_analysis #neurology #psychiatry

[#Neurophet_Issue]    Neurophet and AriBio, collaborate to develop next-generation platform for Alzheimer's diagnosis!    This collaboration leverages Neurophet's medical image analysis technology and AriBio’s clinical trial data analysis expertise for developing the advanced diagnostic platform.    Read more👉 https://bit.ly/3U8FLC0     #Neurophet #AriBio #Alzheimers #NextGen_Platform #brain_image_analysis  

[#Neurophet_Issue] 　 뉴로핏과 AriBio가 ‘차세대 알츠하이머 진단 플랫폼’ 공동 개발에 나섭니다!🤲  　 뉴로핏이 보유한 MRI 활용 뇌 영상 분석 기술과 아리바이오의 혈액 기반 바이오마커를 이용한 검사를 결합해 새로운 방식의 알츠하이머 진단 플랫폼을 구성합니다.🧠  　 기존 알츠하이머 확진 방법의 한계를 극복하기 위한 양사의 연구 협력이 기대되는데요!  　 아래 링크에서 관련 보도자료를 확인해보세요!  　 #뉴로핏 #아리바이오 #연구협력 #차세대_알츠하이머병_진단_플랫폼 #Neurophet #AriBio #Alzheimer’s_Disease

[#Neurophet_Conference] Last week, we showcased our solutions at ESNR 2024. It was great to have a discussion on how our advanced AI solutions can enhance your medical image analysis for brain disorders.🧠 A special highlight was our new technology to analyze Multiple Sclerosis (MS) lesion. MS happens most commonly in young to middle-aged adults, more in females than males, and is more prevalent among those of northern European or Scandinavian ancestry. Asia continues to have a lower incidence of MS. Stay tuned for more developments as we expand our technology to break brain disorders. Thank you to everyone who visited our booth and showed interest in our products!👋 #Neurophet #ESNR #Paris #France #Neuroradiology #AI #brain #MRI #PET #neuroimaging #brain_image_analysis